Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Chris MacDonald

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Teladoc (TDOC) was one of the top beneficiaries of the COVID-19 pandemic. The telemedicine provider shot into the spotlight in 2020, as the market suddenly realized its growth potential. With patients increasingly choosing to have their medical needs met online, shares soared nearly 300% from the start of January to their peak near $294 set in February 2021. 

But as quickly as it shot up, Teladoc shares have fallen from their peak to trade near $10 now. Shares are down more than 80% over the past three years and are down 26% over the past 52 weeks. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.